BTIS
PTLA

BB&T Investment Services’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

BB&T Investment Services’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$3K Hold
63
– – ﹤0.01% 1219
2017
Q3 		$3K Buy
+63
New +$3.7K ﹤0.01% 1042

Other funds holding PTLA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.79B AUM 30.56% 1-Year Est. Return

BB&T Investment Services's PTLA Position: Q4 2017 in Review

BB&T Investment Services held its Portola Pharmaceuticals, Inc. (PTLA) position steady in Q4 2017 at 63 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #1219.

BB&T Investment Services first reported a position in PTLA in Q3 2017 and has held it in 2 quarters since. 215 funds tracked by Wall St. Rank hold PTLA as of Q4 2017.

  • BB&T Investment Services held 63 shares of Portola Pharmaceuticals, Inc. worth $3K as of Q4 2017.
  • BB&T Investment Services left its Portola Pharmaceuticals, Inc. share count unchanged in Q4 2017.
  • Portola Pharmaceuticals, Inc. made up ﹤0.01% of BB&T Investment Services's portfolio in Q4 2017, its #1219 holding.
  • BB&T Investment Services first reported a position in Portola Pharmaceuticals, Inc. in Q3 2017 and has held it in 2 quarters since.
  • 215 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q4 2017.

Based on BB&T Investment Services's 13F filing for Q4 2017, filed 15 Feb 2018.